AQR Capital Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Buy |
159,162
+114,714
| +258% | +$303K | ﹤0.01% | 2708 |
|
|
2025
Q1 | $134K | Buy |
44,448
+29,297
| +193% | +$88.2K | ﹤0.01% | 2960 |
|
|
2024
Q4 | $38.8K | Sell |
15,151
-39,736
| -72% | -$102K | ﹤0.01% | 2825 |
|
|
2024
Q3 | $204K | Buy |
54,887
+6,435
| +13% | +$23.9K | ﹤0.01% | 2558 |
|
|
2024
Q2 | $306K | Buy |
48,452
+29,727
| +159% | +$188K | ﹤0.01% | 2259 |
|
|
2024
Q1 | $101K | Buy |
+18,725
| New | +$101K | ﹤0.01% | 2338 |
|
|
2021
Q1 | – | Sell |
-45,338
| Closed | -$604K | – | 2225 |
|
|
2020
Q4 | $604K | Sell |
45,338
-15,555
| -26% | -$207K | ﹤0.01% | 1718 |
|
|
2020
Q3 | $422K | Buy |
+60,893
| New | +$422K | ﹤0.01% | 1796 |
|